Impact of Tacrine in the Care of Patients With Alzheimer's Disease: What We Know One Year After FDA Approval: Committee on Aging: Group for the Advancement of Psychiatry. Am J Geriatr Psychiatry. 1994 Autumn;2(4):285-289. Epub 2013 Jan 28 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.